Novavax Advances Development of Novel COVID-19 Vaccine
Go back to Novavax Advances Development of Novel COVID-19 Vaccine| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 7.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.95 | 52 Week High | $9.23 | |||
| Open | $7.91 | 52 Week Low | $1.16 | |||
| Day High | $7.99 | P/E | N/A | |||
| Day Low | $7.83 | EPS | $-0.30 | |||
| Volume | 986,567 | |||||
